March-in Rights and Compulsory Licensing of Biopharmaceutical Inventions -

Very few topics in international intellectual property have been as controversial as compulsory licensing. In the US, consumer groups have increasingly focused on march-in rights as a mechanism to lower drug costs. The October 2017 issue of Sterne Kessler’s Global Patent Prosecution Newsletter includes information on march-in rights in the US and the use of compulsory licenses worldwide.